Form 4: Solid Biosciences Director Ilan Ganot Reports Stock Transactions

Director Ilan Ganot reports acquisition and disposition of Solid Biosciences Inc. stock and restricted stock units, including sales to cover withholding taxes.

Summary

• On January 27, 2025, Ilan Ganot, a director of Solid Biosciences Inc., reported transactions involving the company's stock.
• These transactions included the acquisition of common stock through the conversion of restricted stock units and the sale of common stock to cover withholding taxes.
• Specifically, 388 shares were acquired indirectly through his wife and 3,883 shares were acquired directly through conversion of restricted stock units.
• A sale of 144 shares was executed at $3.1096 per share to cover withholding taxes related to vesting restricted stock units.
• Following these transactions, Mr. Ganot directly owns 98,690 shares of common stock and indirectly owns 11,689 shares through his wife.
• He also indirectly holds 19,394 shares through a trust and owns 3,884 restricted stock units directly and 389 indirectly through his wife.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities and beneficial ownership of company stock.

Stakeholder Impact

• The transactions provide shareholders with insight into the actions of a company director, which can influence investor sentiment.

Key Dates